Company:  ARIAD PHARMACEUTICALS INC (ARIA)
Form Type:  8-K
Filing Date:  8/2/2012 
CIK:  0000884731 
Address:  26 LANDSDOWNE ST 
City, State, Zip:  CAMBRIDGE, Massachusetts 02139 
Telephone:  (617) 494-0400 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$7.93  
Change: 
0.02 (0.25%)  
Trade Time: 
Jul 06  
Market Cap: 
$1.50B
Trade ARIA now with

Description of Business
The following Business Section contains forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain risks, uncertainties and other factors including the risk factors set forth in Part I, Item 1A of this annual report. Unless the content requires otherwise, references to "ARIAD," "company," "we," "our," and "us," in this annual report refer to ARIAD Pharmaceuticals, Inc. and our subsidiaries. Overview ARIAD is a global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. Our mission is to discover, develop and commercialize small-molecule drugs to treat cancer in patients with the greatest unmet medical need - aggressive cancers where current therapies are inadequate.
Register and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      ITEM 2.02 Results of Operations and Financial Condition.
    SECTION 7 REGULATION FD
      ITEM 7.01 Regulation FD Disclosure.
    SECTION 8 OTHER EVENTS
      ITEM 8.01 Other Events.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      ITEM 9.01 Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 99.1
    INCOME STATEMENT
    BALANCE SHEET
    CASH FLOW